drugset / Trial / NCT00056095
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplant may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: This phase II trial is studying how well allogeneic stem cell transplant works in treating patients with metastatic kidney cancer.
Timeline
- Start
- 2002-11-04
- Primary completion
- 2008-02-13
- Completion
- 2016-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | Cyclosporine | Peptide | — | — |
| Background | Fludarabine | Small molecule | — | Intravenous |
| Background | therapeutic allogeneic lymphocytes | Cell therapy | — | — |